Abstract

Background: Magnesium sulfate (MgSO4) is proven to be a neuroprotectant which functions to reduce the risk of cerebral palsy in premature infants, but the effects on the short-term outcome of newborns are still contradictory. This study aimed to analyze differences in short-term outcomes and serum magnesium levels in newborns after given MgSO4 therapy.
Methods: This was a prospective cohort study. Subjects were divided into two groups involved preterm infants from mothers who received MgSO4 and pregnant women who did not received MgSO4 as a control.
Results: Among sixty subjects, there were significant differences in outcomes for gestational age infants and respiratory distress syndrome (RDS) between two groups (p = 0.011 and p = 0.013, respectively). Whereas, the significance results were found in birth weight (p = 0.306), Apgar scores 1 (p = 0.816) and 5 minutes (p = 0.924), the use of ventilators (p = 0.335), sepsis (p = 0.276), mortality (p = 0.754), and umbilical artery pH (p = 0.123). The magnesium serum levels of mothers who received MgSO4 and control were 3.45±1.65 mg/dl and 1.78±0.23 mg/dl, respectively (p = 0.001), and infants who received MgSO4 and control were 3.10±1.35 mg/dl and 1.74±0.19 mg/dl, respectively (p = 0.001).
Conclusion: There were significant differences in infant outcomes only at gestational age and RDS. The magnesium serum levels of newborns in therapy group were higher than control.

References

  • Basu SK, Chickajajur V, Lopez V, Bhutada A, Pagala M, Rastogi S, (2011) Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection. Journal of perinatal medicine 40(2): 185-189. https://doi.org/10.1515/JPM.2011.094
  • Burn SC, Burn MS, Burn P, (2018) Maternal Obesity and its Impact on Neonatal Morbidity.
  • Costantine MM, Weiner SJ, (2009) Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstetrics and gynecology 114(2 Pt 1): 354-364. https://doi.org/10.1097/AOG.0b013e3181ae98c2
  • Das M, Chaudhuri PR, Mondal BC, Mitra S, Bandyopadhyay D, Pramanik S, (2015) Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen. Indian journal of pharmacology 47(5): 502-508. https://doi.org/10.4103/0253-7613.165183
  • Dewi R, Supriyatno B, Madjid AS, Gunanti, Lubis M, (2016) The effects of colloids or crystalloids on acute respiratory distress syndrome in swine (Sus scrofa) models with severe sepsis: Analysis on extravascular lung water, IL-8, and VCAM-1. Medical Journal of Indonesia 25(1): 33-38. https://doi.org/10.13181/mji.v25i1.1204
  • Group MTF-USC, (2007) The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG : an international journal of obstetrics and gynaecology 114(3): 300-309. https://doi.org/10.1111/j.1471-0528.2006.01166.x
  • Magee L, Sawchuck D, Synnes A, von Dadelszen P, Basso M, Crane JM, Doyle L, Ehman W, Gagnon R, Grobman W, (2011) Magnesium sulphate for fetal neuroprotection. Journal of Obstetrics and Gynaecology Canada 33(5): 516-529.
  • Pasaribu HP, Hariman H, Roeshadi RH, Koh SCL, (2016) Soluble vascular cell adhesion molecule-1 and magnesium sulfate with nifedipine treatment in Indonesian women with severe pre-eclampsia. Interventional Medicine and Applied Science 8(3): 97-102. https://doi.org/10.1556/1646.8.2016.3.4
  • Putri AR, Ansar J, Arsyad DS, (2018) Descriptive epidemiology of neonatal mortality in Gowa district 2015. In: International Conference on Medical and Health Informatics. Association for Computing Machinery https://doi.org/10.1145/3242789.3242827
  • Qari SA, Alsufyani AA, Muathin SH, El Margoushy NM, (2018) Prevalence of respiratory distress syndrome in neonates. The Egyptian journal of hospital medicine 70(2): 257-264.
  • Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, Iams JD, Wapner RJ, Sorokin Y, Alexander JM, (2008) A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. New England Journal of Medicine 359(9): 895-905.
  • Salfi QN, Saharso D, Atika A, (2019) Profile of Cerebral Palsy Patients in Dr. Soetomo General Hospital Surabaya, Indonesia. Biomolecular and Health Science Journal 2(1): 13-16.
  • Sheikh M, Zoham MH, Hantoushzadeh S, Shariat M, Dalili H, Amini E, (2016) Umbilical blood gas analysis in preeclamptic versus healthy pregnancies with preterm birth. The Journal of Maternal-Fetal & Neonatal Medicine 29(15): 2548-2553.
  • Simhan HN, (/2018) Umbilical cord blood acid-base analysis at delivery.
  • Sukatendel K, Hasibuan CL, Pasaribu HP, Sihite H, Ardyansah E, Situmorang MF, (2018) Risk factor for preterm labor in Haji Adam Malik General Hospital, Pirngadi General hospital and satellite hospitals in Medan from January 2014 to December 2016. In: IOP Conference Series Earth and Environmental Science Vol. 125. Institute of Physics Publishing https://doi.org/10.1088/1755-1315/125/1/012192
  • World Health Organization, (2015) WHO recommendations on interventions to improve preterm birth outcomes: evidence base. World Health Organization
  • Yudrika A, Zulkifli A, Muis M, (2018) Risk factors of neonatal mortality incidence in Muna regency in 2014. In: International Conference on Medical and Health Informatics. https://doi.org/10.1145/3239438.3239489
  • Zeng X, Xue Y, Tian Q, Sun R, An R, (2016) Effects and safety of magnesium sulfate on neuroprotection: a meta-analysis based on PRISMA guidelines. Medicine 95(1):.
  • Zenita DP, Utomo MT, Darmawan E, (2018) The Effect of Antenatal Corticosteroid Therapy to Respiratory Distress Syndrome Event on Preterm Infants in Surabaya. Biomolecular and Health Science Journal 1(1): 40-42.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.